Company / Total Assets
TG Therapeutics, Inc. Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$1.1B
FY2025
5-year range
$193.6M / $1.1B
FY2021-FY2025
Trend
+84.1%
vs FY2024
Sector context
#80 of 214
Health Care
What the data says
At $1.1B, TG Therapeutics, Inc.'s total assets ranks #80 of 214 in the Health Care sector. Total Assets has increased for 3 consecutive years, from $194M in FY2022 to $1.1B in FY2025.
Based on SEC 10-K filings.
$1.1B in FY2025 with a 5-year CAGR of +11.2%.
Improved from $330M to $1.1B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +76.4%
- 5-Year CAGR
- +11.2%
- 10-Year CAGR
- -
Sector benchmark
#80 of 214 in Health CareTop 37% of 214This company $1.1B Sector average $7.5B
▼
-85.8% below sector average
Key checks
Key Insights
- TG Therapeutics, Inc.'s total assets has grown for 3 consecutive years.
- 5-year CAGR of +11.2%, indicating consistent growth.
- In FY2025, total assets increased 84.1% year-over-year.
- Ranks #80 out of 214 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 1.05 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.1B | +84.1% |
| FY2024 | $577.7M | +75.3% |
| FY2023 | $329.6M | +70.3% |
| FY2022 | $193.6M | -49.0% |
| FY2021 | $379.6M | -39.3% |
| FY2020 | $625.6M | +283.8% |
| FY2019 | $163.0M | +95.0% |
| FY2018 | $83.6M | -14.1% |
| FY2017 | $97.4M | +77.8% |
| FY2016 | $54.8M | -51.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026